In GEPIA, ACOT2 was significantly higher upregulated in AML compared with that of normal samples (Figures 1(g) and 1(h)), yet there was no significant difference in ACOT1 (Figures 1(c) and 1(d)), ACOT4 (Figures 1(k) and 1(l)), and ACOT6 (Figures 1(o) and 1(p)) between AML and normal samples. This evidence concerns the gene ACOT6 and acute myeloid leukemia.